Tamoxifen

serpin family C member 1 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35086148 Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort. 2022 May 10 1
2 17709798 Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. 2007 Sep 20 1
3 12492585 Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial. 2003 Jan 3
4 12783932 A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. 2003 Jun 4 1
5 8790074 Effect of tamoxifen on measurements of hemostasis in healthy women. 1996 Sep 9 1
6 8905024 The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study. 1996 Sep 1
7 8148487 The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis. 1993 Dec 1
8 8350363 Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. 1993 Sep 1 1
9 1739360 Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy. 1992 Feb 2
10 3228593 Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels. 1988 Dec 1
11 3345487 Effects of tamoxifen on blood coagulation. 1988 Apr 1 1
12 3607780 Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III. 1987 Aug 15 1
13 6426771 Tamoxifen treatment of metastatic breast cancer and antithrombin III levels. 1984 Jun 15 2